New data suggest that brain changes in the posterior cingulate cortex and precuneus as a result of SDB may increase the risk of Alzheimer disease, supporting prior findings which imply a link between the conditions.
In episode 7, Patricia Coyle MD, discusses the phase 2 APLIOS bioequivalence study on B-cell depletion with the subcutaneous administration of ofatumumab in relapsing multiple sclerosis.
Study data suggest that even in early disease, motor complications are common and accompanied by a greater burden of nonmotor symptoms than previously known.
